The Comprehensive Systematic Review of Efficacy of Dietary Supplements for Headaches
Keywords:
Dietary Supplements, Migraine Prophylaxis, Nutraceuticals, Headache Disorders, Omega-3 Fatty Acids, Riboflavin, Magnesium, Systematic ReviewAbstract
Introduction: Migraine and other primary headache disorders represent a significant global health burden, often inadequately managed by conventional pharmacotherapy due to issues of efficacy, side effects, and patient preference. This has spurred interest in dietary supplements as potential prophylactic and therapeutic alternatives. This report synthesizes the current evidence on the efficacy and safety of various dietary supplements for headache management.
Methods: A systematic approach was employed to identify relevant studies involving participants with primary headache disorders, interventions with standalone dietary supplements, and quantitative headache-related outcomes. Data were extracted on supplement details, headache types, participant characteristics, outcomes, efficacy results, study design, and safety profiles from included studies.
Results: The analysis demonstrated significant efficacy for several supplements. Omega-3 fatty acids, particularly when combined with reduced omega-6 intake (H3-L6 diet), reduced headache days by 4.0 days per month (Ramsden et al., 2021). High-dose EPA/DHA outperformed FDA-approved prophylactic medications in a network meta-analysis (Tseng et al., 2023). Vitamin B2 (400 mg/day) significantly reduced migraine frequency and showed comparable efficacy to sodium valproate with fewer side effects (Chen et al., 2021; Rahimdel et al., 2015). Magnesium (500-600 mg/day), Coenzyme Q10, vitamin D, and butterbur also showed consistent benefits. B-vitamin combinations were effective, particularly in individuals with specific MTHFR genotypes (Lea et al., 2009; Menon et al., 2012). Probiotics, curcumin, alpha-lipoic acid, and minerals like zinc and selenium also demonstrated positive effects. Combination therapies (e.g., CoQ10 + L-carnitine, omega-3 + nano-curcumin) often showed synergistic benefits.
Discussion: The efficacy of supplements is moderated by factors such as dosage, formulation, genetic makeup (e.g., MTHFR status), headache chronicity, and age. Supplements appear to work through diverse mechanisms including anti-inflammation, mitochondrial support, oxidative stress reduction, and neuromodulation. They present a favorable safety profile compared to many pharmaceutical preventatives.
Conclusion: A robust body of evidence supports the use of specific dietary supplements—including omega-3 fatty acids, riboflavin, magnesium, CoQ10, and vitamin D—as effective and generally safe options for the prophylaxis of migraines and other primary headaches. They offer viable alternatives or adjuncts to conventional pharmacotherapy, especially for patients seeking fewer side effects or with specific biological predispositions. Future research should focus on long-term safety, optimal dosing protocols, and personalized supplementation strategies based on biomarkers and genetics.
References
A. Rahimdel, Ahmad Zeinali, Pouria Yazdian-anari, Rahele Hajizadeh, and Ehsan Arefnia. “Effectiveness of Vitamin B2 Versus Sodium Valproate in Migraine Prophylaxis: A Randomized Clinical Trial.” Electronic Physician, 2015.
A. Slomski. “Diets High in Omega-3 Fatty Acids Might Ease Migraines.” Journal of the American Medical Association (JAMA), 2021.
———. “Optimal Medical Therapy Prolongs Life Following Revascularization.” Journal of the American Medical Association (JAMA), 2021.
A. Zareie, A. Sahebkar, F. Khorvash, Mohammad Bagherniya, A. Hasanzadeh, and G. Askari. “Effect of Cinnamon on Migraine Attacks and Inflammatory Markers: A Randomized Double‐blind Placebo‐controlled Trial.” Phytotherapy Research, 2020.
A. Zareie, Mohammad Bagherniya, Manoj Sharma, F. Khorvash, A. Hasanzadeh, and G. Askari. “Effects of Cinnamon on Anthropometry Status and Headache Disability of Migraine Patients: A Randomized Double-Blind Placebo-Controlled Trial,” 2020.
Abed Ghavami, F. Khorvash, S. Khalesi, Z. Heidari, and G. Askari. “The Effects of Synbiotic Supplementation on Oxidative Stress and Clinical Symptoms in Women with Migraine: A Double‐blind, Placebo‐controlled, Randomized Trial.” Journal of Functional Foods, 2021.
Ali Tarighat Esfanjani, R. Mahdavi, Mehrangiz Ebrahimi Mameghani, M. Talebi, Zeinab Nikniaz, and A. Safaiyan. “The Effects of Magnesium, l-Carnitine, and Concurrent Magnesium–l-Carnitine Supplementation in Migraine Prophylaxis.” Biological Trace Element Research, 2012.
Arghavan Balali, Omid Sadeghi, F. Khorvash, M. Rouhani, and Gholamreza Askari. “The Effect of Selenium Supplementation on Oxidative Stress, Clinical and Physiological Symptoms in Patients with Migraine: A Double-Blinded Randomized Clinical Trial.” Frontiers in Nutrition, 2024.
Athaillah Athaillah, Y. Dimyati, Johannes H. Saing, B. Saing, Hakimi Hakimi, and A. Lelo. “Riboflavin as Migraine Prophylaxis in Adolescents,” 2012.
Bizhan Helli, Foroogh Anjirizadeh, A. Mehramiri, Davood Shalilahmadi, and S. Latifi. “The Effect of Ginger (Zingiber Officinale Rosc.) Consumption in Headache Prophylaxis in Patients with Migraine: A Randomized Placebo-Controlled Clinical Trial.” Jundishapur Journal of Natural Pharmaceutical Products, 2022.
Briant E Burke, R. Olson, and B. Cusack. “Randomized, Controlled Trial of Phytoestrogen in the Prophylactic Treatment of Menstrual Migraine.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2002.
C. F. Ribeiro, and For The Portuguese Headache Society. “L‐5‐Hydroxytryptophan in the Prophylaxis of Chronic Tension‐type Headache: A Double‐Blind, Randomized, Placebo‐Controlled Study.” Headache, 2000.
C. Gaul, H. Diener, and U. Danesch. “Improvement of Migraine Symptoms with a Proprietary Supplement Containing Riboflavin, Magnesium and Q10: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial.” The Journal of Headache and Pain, 2015.
C. Ramsden, Christopher E Ramsden, J. Mann, K. Faurot, C. Lynch, Syed Taha Imam, B. MacIntosh, et al. “Low Omega-6 Vs. Low Omega-6 Plus High Omega-3 Dietary Intervention for Chronic Daily Headache: Protocol for a Randomized Clinical Trial.” Trials, 2011.
C. Ramsden, Daisy Zamora, K. Faurot, B. MacIntosh, M. Horowitz, G. Keyes, Zhi-Xin Yuan, et al. “Dietary Alteration of n-3 and n-6 Fatty Acids for Headache Reduction in Adults with Migraine: Randomized Controlled Trial.” British Medical Journal, 2021.
Chen Hu, Yilin Fan, Shaoping Wu, Yu-Ting Zou, and Xiaosu Qu. “Vitamin D Supplementation for the Treatment of Migraine: A Meta-Analysis of Randomized Controlled Studies.” American Journal of Emergency Medicine, 2021.
Csaba Ertsey, Parisa Gazerani, F. Haghdoost, KR Faurot, CE GaylordSALynch, CE Ramsden, BA MacIntosh, et al. “Dietary Fatty Acids Improve Perceived Sleep Quality, Stress, and Health in Migraine: A Secondary Analysis of a Randomized Controlled Trial.” Frontiers in Pain Research, 2023.
Elena C. Gross, Niveditha Putananickal, A. Orsini, S. Schmidt, D. Vogt, S. Cichon, P. Sandor, and D. Fischer. “Efficacy and Safety of Exogenous Ketone Bodies for Preventive Treatment of Migraine: A Study Protocol for a Single-Centred, Randomised, Placebo-Controlled, Double-Blind Crossover Trial.” Trials, 2019.
Eliane Cristina Ferro, A. Biagini, Í. E. F. da Silva, M. L. Silva, and J. R. Silva. “The Combined Effect of Acupuncture and Tanacetum Parthenium on Quality of Life in Women with Headache: Randomised Study.” Acupuncture in Medicine, 2012.
Emna Ellouz, and I. Ketata. “Prophylactic Effectiveness of Coenzyme Q10 for Migraine in Adults: A Systematic Review and Meta-Analysis of Double-Blinded Randomized Clinical Trials.” Traditional and Integrative Medicine, 2025.
Fahimeh Martami, M. Togha, Maryam Seifishahpar, Zeinab Ghorbani, H. Ansari, Tahereh Karimi, and S. R. Jahromi. “The Effects of a Multispecies Probiotic Supplement on Inflammatory Markers and Episodic and Chronic Migraine Characteristics: A Randomized Double-Blind Controlled Trial.” Cephalalgia, 2019.
G. Askari, M. Nasiri, H. Mozaffari‐khosravi, M. Rezaie, M. Bagheri-Bidakhavidi, and O. Sadeghi. “The Effects of Folic Acid and Pyridoxine Supplementation on Characteristics of Migraine Attacks in Migraine Patients with Aura: A Double-Blind, Randomized Placebo-Controlled, Clinical Trial.” Nutrition (Burbank, Los Angeles County, Calif.), 2017.
G. Okoli, R. Rabbani, H. Kashani, Aleksandra K. Wierzbowski, Christine Neilson, B. Mansouri, R. Zarychanski, and A. Abou-Setta. “Vitamins and Minerals for Migraine Prophylaxis: A Systematic Review and Meta-Analysis.” Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques, 2019.
Guillermo García-Pérez-de-Sevilla, and Ángel Gónzalez-de-la-Flor. “Impact of Fatty Acid Supplementation on Migraine Outcomes: A Systematic Review and Meta-Analysis.” Nutrition Reviews, 2025.
H. Diener, V. Rahlfs, and U. Danesch. “The First Placebo-Controlled Trial of a Special Butterbur Root Extract for the Prevention of Migraine: Reanalysis of Efficacy Criteria.” European Neurology, 2004.
Hedieh Ahmadi, Seyedeh Shabnam Mazloumi-Kiapey, O. Sadeghi, M. Nasiri, F. Khorvash, Tayebeh Mottaghi, and G. Askari. “Zinc Supplementation Affects Favorably the Frequency of Migraine Attacks: A Double-Blind Randomized Placebo-Controlled Clinical Trial.” Nutrix Journal, 2020.
Hong-wei Liu, Yihuai Zou, K. Cao, Li-hua Yu, Yong Zhang, Caihong Fu, and Dayong Ma. “Efficacy of Modified Wuzhuyu Decoction Granule (加减吴茱萸汤 颗粒剂) for Migraine Patients with Cold and Stasis Obstructing Meridian Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.” Chinese Journal of Integrative Medicine, 2018.
Hossein Azizi, A. Shojaii, Fataneh Hashem-Dabaghian, M. Noras, A. Boroumand, Bita Ebadolahzadeh Haghani, and R. Ghods. “Effects of Valeriana Officinalis (Valerian) on Tension-Type Headache: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial.” Avicenna Journal of Phytomedicine, 2020.
Hsueh-Fang Wang, Wen-Chun Liu, Halliru Zailani, Cheng-Chia Yang, Ting-Bin Chen, Ching-Mao Chang, I-Ju Tsai, Chun-Pai Yang, and Kuan-Pin Su. “A 12-Week Randomized Double-Blind Clinical Trial of Eicosapentaenoic Acid Intervention in Episodic Migraine.” Brain, Behavior, and Immunity, 2024.
Ioannis Liampas, V. Siokas, Athina-Maria Aloizou, Z. Tsouris, Dastamani Metaxia, Paraskevi Aslanidou, A. Brotis, and E. Dardiotis. “Pyridoxine, Folate and Cobalamin for Migraine: A Systematic Review.” Acta Neurologica Scandinavica, 2020.
J. Izquierdo-Casas, Oriol Comas-Basté, M. Latorre-Moratalla, Marian Lorente-Gascón, Adriana Duelo, L. Soler-Singla, and M. Vidal-Carou. “Diamine Oxidase (DAO) Supplement Reduces Headache in Episodic Migraine Patients with DAO Deficiency: A Randomized Double-Blind Trial.” Clinical Nutrition, 2018.
K. Faurot, M. Horowitz, C. Ramsden, J. Mann, and Daisy Zamora. “Effect of Dietary Fatty Acids on Sleep and Stress Among Adults With Migraine: Secondary Analysis of a Randomized Controlled Trial.” Current Developments in Nutrition, 2022.
L. Amini, O. Yaghini, M. Ghazavi, and N. Aslani. “L-Carnitine Versus Propranolol for Pediatric Migraine Prophylaxis.” Iranian Journal of Child Neurology, 2021.
M. Abdolahi, A. Tafakhori, M. Togha, A. Okhovat, Feridoun Siassi, M. Eshraghian, Mohsen Sedighiyan, Mona Djalali, Niyaz Mohammadzadeh Honarvar, and M. Djalali. “The Synergistic Effects of ω-3 Fatty Acids and Nano-Curcumin Supplementation on Tumor Necrosis Factor (TNF)-α Gene Expression and Serum Level in Migraine Patients.” Immunogenetics, 2017.
M. Abdolahi, Arash Jafarieh, P. Sarraf, Mohsen Sedighiyan, A. Yousefi, A. Tafakhori, H. Abdollahi, F. Salehinia, and M. Djalali. “The Neuromodulatory Effects of ω-3 Fatty Acids and Nano-Curcumin on the COX-2/ iNOS Network in Migraines: A Clinical Trial Study from Gene Expression to Clinical Symptoms.” Endocrine, Metabolic & Immune Disorders - Drug Targets, 2019.
M. Jafarpour, G. Yousefi, A. Hamedi, Abdolhamid Shariat, A. Salehi, and M. Heydari. “Effect of a Traditional Syrup from Citrus Medica L. Fruit Juice on Migraine Headache: A Randomized Double Blind Placebo Controlled Clinical Trial.” Journal of Ethnopharmacology, 2016.
M. Maghbooli, F. Golipour, Alireza Moghimi Esfandabadi, and Mehran Yousefi. “Comparison Between the Efficacy of Ginger and Sumatriptan in the Ablative Treatment of the Common Migraine.” Phytotherapy Research, 2014.
M. Mazaheri, Arash Mosarrezaii Aghdam, M. Heidari, and Rasoul Zarrin. “Assessing the Effect of Zinc Supplementation on the Frequency of Migraine Attack, Duration, Severity, Lipid Profile and Hs-CRP in Adult Women.” Clinical Nutrition Research, 2021.
M. Parohan, P. Sarraf, M. Javanbakht, Sakineh Ranji-Burachaloo, and M. Djalali. “Effect of Coenzyme Q10 Supplementation on Clinical Features of Migraine: A Systematic Review and Dose–Response Meta-Analysis of Randomized Controlled Trials.” Nutritional Neuroscience, 2019.
Maedeh Babapour, F. Khorvash, M. Rouhani, Abed Ghavami, Hatav Ghasemi-Tehrani, Zahra Heidari, M. Karbasi, F. Moradi, and G. Askari. “Effect of Soy Isoflavones Supplementation on Migraine Characteristics, Mental Status and Calcitonin Gene-Related Peptide (CGRP) Levels in Women with Migraine: Results of Randomised Controlled Trial.” Nutrix Journal, 2022.
Mahnaz Rezaei Kelishadi, A. Naeini, F. Khorvash, G. Askari, and Zahra Heidari. “The Beneficial Effect of Alpha-Lipoic Acid Supplementation as a Potential Adjunct Treatment in Episodic Migraines.” Scientific Reports, 2022.
Mahtab Karami Talandashti, Hossein Shahinfar, Pedram Delgarm, and S. Jazayeri. “Effects of Selected Dietary Supplements on Migraine Prophylaxis: A Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials.” Neurological Sciences, 2024.
Mehrnaz Shojaei, F. Khorvash, A. Sahebkar, T. Sathyapalan, and Mohammad Bagherniya. “Effect and Safety of Phytosomal Curcumin Supplementation on Migraine Patients: A Randomized, Double-Blind and Placebo-Controlled Trial.” Chinese Journal of Integrative Medicine, 2025.
Mohammad Ali Askari, Mahdi Vajdi, F. Khorvash, and Afsaneh Yegdaneh. “Effect of Mixodin Supplementation on Inflammatory and Oxidative Stress Markers, Clinical Symptoms, Mental Health, and Quality of Life in Patients with Migraine: Study Protocol for a Randomized Clinical Trial.” Trials, 2025.
Mohsen Sedighiyan, E. Jafari, Sara Sohrabi Athar, M. Yekaninejad, E. Alvandi, M. Abdolahi, and M. Djalali. “The Effects of Nano-Curcumin Supplementation on Leptin and Adiponectin in Migraine Patients: A Double-Blind Clinical Trial Study from Gene Expression to Clinical Symptoms.” Endocrine, Metabolic & Immune Disorders - Drug Targets, 2022.
N. Karimi, A. Razian, and M. Heidari. “The Efficacy of Magnesium Oxide and Sodium Valproate in Prevention of Migraine Headache: A Randomized, Controlled, Double-Blind, Crossover Study.” Acta Neurologica Belgica, 2019.
N. Wolkodoff, G. Haase, and Reginald W. Kapteyn. “A Unique Medium Chain Triglyceride-Containing Micronutrient Complex: Effects on Migraine Symptoms Compared to Quality of Lif.” World Journal of Advanced Research and Reviews, 2022.
———. “Effects Of A Phytonutrient Complex On Migraine: Comparison Of Overall Episodes To Quality Of Life Factors.” Medicine &Amp; Science in Sports &Amp; Exercise, 2022.
Neda Soveyd, M. Abdolahi, M. Djalali, M. Hatami, A. Tafakhori, P. Sarraf, and Niyaz M. Honarvar. “The Combined Effects of ω -3 Fatty Acids and Nano-Curcumin Supplementation on Intercellular Adhesion Molecule-1 (ICAM-1) Gene Expression and Serum Levels in Migraine Patients.” CNS and Neurological Disorders - Drug Targets, 2017.
Niyaz M. Honarvar, Neda Soveid, M. Abdolahi, M. Djalali, M. Hatami, and N. H. Karzar. “Anti-Neuroinflammatory Properties of n-3 Fatty Acids and Nano-Curcumin on Migraine Patients, from Cellular to Clinical Insight: A Randomized, Double Blind, and Placebo-Controlled Trial.” Endocrine, Metabolic & Immune Disorders - Drug Targets, 2020.
O. Sadeghi, M. Nasiri, Zahra Maghsoudi, N. Pahlavani, M. Rezaie, and G. Askari. “Effects of Pyridoxine Supplementation on Severity, Frequency and Duration of Migraine Attacks in Migraine Patients with Aura: A Double-Blind Randomized Clinical Trial Study in Iran.” Iranian Journal of Neurology, 2015.
O. Yaghini, N. Hoseini, M. Ghazavi, Vahid Mansouri, J. Nasiri, Toktam Moosavian, and M. Salehi. “A Comparative Study on the Efficacy of Coenzyme Q10 and Amitriptyline in the Prophylactic Treatment of Migraine Headaches in Children: A Randomized Controlled Trial.” Advanced Biomedical Research, 2022.
P. Gazerani, Randi Fuglsang, J. Pedersen, J. Sørensen, J. Kjeldsen, Hanim Yassin, and B. Nedergaard. “A Randomized, Double-Blinded, Placebo-Controlled, Parallel Trial of Vitamin D3 Supplementation in Adult Patients with Migraine.” Current Medical Research and Opinion, 2018.
P. Hajihashemi, G. Askari, F. Khorvash, Mohammad Reza Maracy, and M. Nourian. “The Effects of Concurrent Coenzyme Q10, L-Carnitine Supplementation in Migraine Prophylaxis: A Randomized, Placebo-Controlled, Double-Blind Trial.” Cephalalgia, 2019.
P. Tseng, Bing-Yan Zeng, Jiann-Jy Chen, Chun-Hsien Kuo, Bing-Syuan Zeng, John S. Kuo, Yu-Shian Cheng, et al. “High Dosage Omega-3 Fatty Acids Outperform Existing Pharmacological Options for Migraine Prophylaxis: A Network Meta-Analysis.” Advances in Nutrition, 2023.
R. Lea, Natalie Colson, S. Quinlan, J. MacMillan, and L. Griffiths. “The Effects of Vitamin Supplementation and MTHFR (C677T) Genotype on Homocysteine-Lowering and Migraine Disability.” Pharmacogenetics & Genomics, 2009.
R. Lipton, H. Göbel, K. Einhäupl, K. Wilks, and A. Mauskop. “Petasites Hybridus Root (Butterbur) Is an Effective Preventive Treatment for Migraine.” Neurology, 2004.
R. Oelkers-Ax, A. Leins, P. Parzer, T. Hillecke, H. Bolay, Jochen Fischer, S. Bender, Uta Hermanns, and F. Resch. “Butterbur Root Extract and Music Therapy in the Prevention of Childhood Migraine: An Explorative Study.” European Journal of Pain, 2008.
S. Menon, B. Nasir, Nesli Avgan, S. Ghassabian, Christopher Oliver, R. Lea, Maree T. Smith, and L. Griffiths. “The Effect of 1 Mg Folic Acid Supplementation on Clinical Outcomes in Female Migraine with Aura Patients.” The Journal of Headache and Pain, 2016.
S. Menon, R. Lea, B. Roy, Michelle Hanna, Shirley Wee, L. Haupt, C. Oliver, and L. Griffiths. “Genotypes of the MTHFR C677T and MTRR A66G Genes Act Independently to Reduce Migraine Disability in Response to Vitamin Supplementation.” Pharmacogenetics & Genomics, 2012.
S. Mojtahedi, M. Abdolahi, Malihe Sadat Rahimi Azghadi, and Mohsen Sedighiyan. “Efficacy of Nano-Curcumin Supplementation on Depression, Anxiety, Stress and Clinical Symptoms in Migraine Patients: A Randomized Double-Blind Clinical Trial.” Current Psychiatry Research and Reviews, 2024.
S. Nematgorgani, Soodeh Razeghi-Jahromi, E. Jafari, M. Togha, Pegah Rafiee, Zeinab Ghorbani, Z. Ahmadi, and Vali Baigi. “B Vitamins and Their Combination Could Reduce Migraine Headaches: A Randomized Double-Blind Controlled Trial.” Current Journal of Neurology, 2022.
S. Slater, T. D. Nelson, M. Kabbouche, Susan L LeCates, P. Horn, A. Segers, P. Manning, S. Powers, and A. Hershey. “A Randomized, Double-Blinded, Placebo-Controlled, Crossover, Add-on Study of CoEnzyme Q10 in the Prevention of Pediatric and Adolescent Migraine.” Cephalalgia, 2011.
Sahar Golpour-Hamedani, Mohammad Bagherniya, F. Khorvash, A. Feizi, Manoj Sharma, and Gholamreza Askari. “The Effects of Concurrent Alpha-Linolenic Acid, L-Carnitine Supplementation on Clinical Symptoms, Mental Health, and Quality of Life in Women with Migraine: A Randomized, Triple-Blind, Placebo-Controlled Trial.” Nutrix Journal, 2025.
Sahar Golpour-Hamedani, Mohammad Bagherniy, F. Khorvash, A. Feizi, Manoj Sharma, and Gholamreza Askari. “Investigating the Effects of Co-Supplementation with Alpha-Linolenic Acid and L-Carnitine on Inflammatory Status, Oxidative Stress, Clinical Symptoms, Mental Health and Quality of Life in Women with Migraine: A Protocol for a Randomized, Triple-Blind, Placebo-Controlled Trial.” Trials, 2024.
Sarah Mousavi, M. Z. Bidaki, Naghmeh Yazdi, Vahid Tafazoli, and M. S. Dinani. “The Effects of Combination Herbal Medicine Tablet on Migraine Headache: A Randomized, Double-Blind, Placebo, Controlled Study.” Journal of Pharmaceutical Care, 2024.
Shahnaz Amani Tirani, F. Khorvash, P. Saneei, Zahra Moradmand, and Gholamreza Askari. “Effects of Probiotic and Vitamin D Co-Supplementation on Clinical Symptoms, Mental Health, and Inflammation in Adult Patients with Migraine Headache: A Randomized, Triple-Blinded, Placebo-Controlled Trial.” BMC Medicine, 2024.
Shahnaz Amani Tirani, P. Saneei, F. Khorvash, and Gholamreza Askari. “Effects of Probiotic and Vitamin D Co-Supplementation on Migraine Index, Quality of Life, and Oxidative Stress in Adults with Migraine Headache: A Randomized Triple-Blinded Clinical Trial.” European Journal of Nutrition, 2025.
Shahram Sadeghvand, M. Barzegar, S. Shiva, Vahid Tarmahi, H. Hamed, Elnaz Rahimi Khamaneh, Zahra Golchinfar, and S. Raeisi. “The Effects of Vitamin B-Complex Supplementation on Serum Homocysteine Levels and Migraine Severity in Children A Randomized Controlled Trial.” Iranian Journal of Child Neurology, 2023.
Shengyuan Yu, Yueqing Hu, Qi Wan, Jiying Zhou, Xinfeng Liu, Xiangyang Qiao, Xiaosu Yang, et al. “A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Duliang Soft Capsule in Patients with Chronic Daily Headache.” Evidence-Based Complementary and Alternative Medicine, 2015.
Sheyda Rezaie, G. Askari, F. Khorvash, M. Tarrahi, and R. Amani. “Effects of Curcumin Supplementation on Clinical Features and Inflammation, in Migraine Patients: A Double-Blind Controlled, Placebo Randomized Clinical Trial.” International Journal of Preventive Medicine, 2021.
Suhairul Sazali, Salziyan Badrin, M. N. Norhayati, and Nur Suhaila Idris. “Coenzyme Q10 Supplementation for Prophylaxis in Adult Patients with Migraine—a Meta-Analysis.” BMJ Open, 2021.
Tayebeh Mottaghi, G. Askari, F. Khorvash, and M. Maracy. “Effect of Vitamin D Supplementation on Symptoms and C-Reactive Protein in Migraine Patients.” Journal of Research in Medical Sciences, 2015.
W. Grossmann, and H. Schmidramsl. “An Extract of Petasites Hybridus Is Effective in the Prophylaxis of Migraine.” Alternative Medicine Review : A Journal of Clinical Therapeutic, 2000.
Xingke Zhu, Min Yang, Zhaoxiang Zen, Xueyan Zhao, Rongzeng Huang, Chengwu Song, Cuiling Guan, and Shuna Jin. “The Role of Curcumin Supplementation in Patients with Migraine: A Meta-Analysis of Randomized Controlled Trial.” medRxiv, 2024.
Yuan-feng Zhang, Zhiqiang Xu, Hongjie Zhou, Ya-zhen Liu, and Xiao-jiang Jiang. “The Efficacy of Vitamin D Supplementation for Migraine: A Meta-Analysis of Randomized Controlled Studies.” Clinical Neuropharmacology, 2021.
Yu-Shiue Chen, Huan-Fang Lee, Ching-Hsuan Tsai, Y. Hsu, Ching-Ju Fang, Chen-Ju Chen, Yu-Hsin Hung, and Fang‐Wen Hu. “Effect of Vitamin B2 Supplementation on Migraine Prophylaxis: A Systematic Review and Meta-Analysis.” Nutritional Neuroscience, 2021.
Z. Harel, G. Gascon, S. Riggs, R. Vaz, W. Brown, and Gerald Exil. “Supplementation with Omega-3 Polyunsaturated Fatty Acids in the Management of Recurrent Migraines in Adolescents.” Journal of Adolescent Health, 2002.
Zeinab Ghorbani, M. Togha, Pegah Rafiee, Z. Ahmadi, Reyhaneh Rasekh Magham, M. Djalali, Sahar Shahemi, et al. “Vitamin D3 Might Improve Headache Characteristics and Protect Against Inflammation in Migraine: A Randomized Clinical Trial.” Neurological Sciences, 2020.
هادی احمدی, طیبه متقی, فریبرز خوروش, آوات فیضی, محمد باقرنیا, and غلامرضا عسکری. “Effect of Zinc Supplementation on Symptoms Among Patients with Migraine.” Journal of Health Systems Research, 2019.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Adrian Saleh (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
